Cargando…

Clinical Outcomes after International Referral of Uveal Melanoma Patients for Proton Therapy

SIMPLE SUMMARY: This study aims to assess cancer control and preservation of the eye and visual acuity after proton therapy abroad for eye melanoma. For this, medical files were reviewed of Dutch uveal melanoma patients who were treated in Switzerland with proton therapy from 1987 to 2019. The tumou...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marinkovic, Marina, Pors, Lennart J., van den Berg, Vincent, Peters, Femke P., Schalenbourg, Ann, Zografos, Leonidas, Pica, Alessia, Hrbacek, Jan, Van Duinen, Sjoerd G., Vu, T. H. Khanh, Bleeker, Jaco C., Rasch, Coen R. N., Jager, Martine J., Luyten, Gregorius P. M., Horeweg, Nanda
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699723/ https://www.ncbi.nlm.nih.gov/pubmed/34944862 http://dx.doi.org/10.3390/cancers13246241

Ejemplares similares

Increased Histological Tumor Pigmentation in Uveal Melanoma Is Related to Eye Color and Loss of Chromosome 3/BAP1
por: Gelmi, Maria Chiara, et al.
Publicado: (2023)

Clinical Outcomes in AYAs (Adolescents and Young Adults) Treated with Proton Therapy for Uveal Melanoma: A Comparative Matching Study with Elder Adults
por: Pica, Alessia, et al.
Publicado: (2023)

Soluble HLA in the Aqueous Humour of Uveal Melanoma Is Associated with Unfavourable Tumour Characteristics
por: Wierenga, Annemijn P. A., et al.
Publicado: (2019)

Automatic Three-Dimensional Magnetic Resonance-based measurements of tumour prominence and basal diameter for treatment planning of uveal melanoma
por: Klaassen, Lisa, et al.
Publicado: (2022)

Good long-term visual outcomes of parapapillary choroidal melanoma patients treated with proton therapy: a comparative study
por: Pica, Alessia, et al.
Publicado: (2020)

MR-based follow-up after brachytherapy and proton beam therapy in uveal melanoma
por: Tang, Michael C. Y., et al.
Publicado: (2023)

Prognostic Factors Five Years After Enucleation for Uveal Melanoma
por: Dogrusöz, Mehmet, et al.
Publicado: (2020)

Fuchs' Adenoma of the Choroid Simulating a Choroidal Hemangioma
por: Razzaq, Lubna, et al.
Publicado: (2012)

Targeting the YAP/TAZ Pathway in Uveal and Conjunctival Melanoma With Verteporfin
por: Brouwer, Niels J., et al.
Publicado: (2021)

RETINAL OXIMETRY IS ALTERED IN EYES WITH CHOROIDAL MELANOMA BUT NOT IN EYES WITH CHOROIDAL NEVI
por: Brouwer, Niels J., et al.
Publicado: (2020)

MR imaging characteristics of uveal melanoma with histopathological validation
por: Ferreira, Teresa A., et al.
Publicado: (2021)

Inter-Observer Variability in MR-Based Target Volume Delineation of Uveal Melanoma
por: Jaarsma-Coes, Myriam G., et al.
Publicado: (2022)

Ischemia Is Related to Tumour Genetics in Uveal Melanoma
por: Brouwer, Niels J., et al.
Publicado: (2019)

Magnetic Resonance Imaging in the Clinical Care for Uveal Melanoma Patients—A Systematic Review from an Ophthalmic Perspective
por: Jaarsma-Coes, Myriam G., et al.
Publicado: (2023)

Microphthalmia-Associated Transcription Factor: A Differentiation Marker in Uveal Melanoma
por: Gelmi, Maria Chiara, et al.
Publicado: (2023)

Differential Expression of DNA Repair Genes in Prognostically-Favorable versus Unfavorable Uveal Melanoma
por: Dogrusöz, Mehmet, et al.
Publicado: (2019)

Iris Colour and the Risk of Developing Uveal Melanoma
por: Houtzagers, Laurien E., et al.
Publicado: (2020)

Tumour Angiogenesis in Uveal Melanoma Is Related to Genetic Evolution
por: Brouwer, Niels J., et al.
Publicado: (2019)

Genetic evolution of uveal melanoma guides the development of an inflammatory microenvironment
por: Gezgin, Gülçin, et al.
Publicado: (2017)

Time Trends in the Treatment and Survival of 5036 Uveal Melanoma Patients in The Netherlands over a 30-Year Period
por: Tong, Thaïs M. L., et al.
Publicado: (2023)

Choroidal metastases in testicular choriocarcinoma, successful treatment with chemo- and radiotherapy: a case report
por: Guber, Ivo, et al.
Publicado: (2011)

Measuring eye deformation between planning and proton beam therapy position using magnetic resonance imaging
por: Jaarsma-Coes, Myriam G., et al.
Publicado: (2020)

A Comparison of 3 T and 7 T MRI for the Clinical Evaluation of Uveal Melanoma
por: Tang, Michael C.Y., et al.
Publicado: (2021)

Loss of BAP1 Is Associated with Upregulation of the NFkB Pathway and Increased HLA Class I Expression in Uveal Melanoma
por: Souri, Zahra, et al.
Publicado: (2019)

Heterogeneity revealed by integrated genomic analysis uncovers a molecular switch in malignant uveal melanoma
por: de Lange, Mark J., et al.
Publicado: (2015)

Tumor-Infiltrating T Cells Can Be Expanded Successfully from Primary Uveal Melanoma after Separation from Their Tumor Environment
por: Gezgin, Gülçin, et al.
Publicado: (2022)

Distribution of GNAQ and GNA11 Mutation Signatures in Uveal Melanoma Points to a Light Dependent Mutation Mechanism
por: de Lange, Mark J., et al.
Publicado: (2015)

The Economic Value of MR-Imaging for Uveal Melanoma
por: Grech Fonk, Lorna, et al.
Publicado: (2020)

Do GNAQ and GNA11 Differentially Affect Inflammation and HLA Expression in Uveal Melanoma?
por: van Weeghel, Christiaan, et al.
Publicado: (2019)

Involvement of mutant and wild-type CYSLTR2 in the development and progression of uveal nevi and melanoma
por: Nell, Rogier J., et al.
Publicado: (2021)

How would you manage this small melanocytic choroidal tumour?
por: Papadopoulou, Domniki, et al.
Publicado: (2012)

EIGHTEEN-MONTH RESULTS OF INTRAVITREAL ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR ON VISION AND MICROCIRCULATION IN RADIATION MACULOPATHY
por: Eandi, Chiara M., et al.
Publicado: (2021)

Upregulation of HLA Expression in Primary Uveal Melanoma by Infiltrating Leukocytes
por: van Essen, T. Huibertus, et al.
Publicado: (2016)

LAG3 and Its Ligands Show Increased Expression in High-Risk Uveal Melanoma
por: Souri, Zahra, et al.
Publicado: (2021)

Expression of HDACs 1, 3 and 8 Is Upregulated in the Presence of Infiltrating Lymphocytes in Uveal Melanoma
por: Souri, Zahra, et al.
Publicado: (2021)

HDAC Inhibition Increases HLA Class I Expression in Uveal Melanoma
por: Souri, Zahra, et al.
Publicado: (2020)

In Uveal Melanoma, Angiopoietin-2 but Not Angiopoietin-1 Is Increased in High-Risk Tumors, Providing a Potential Druggable Target
por: ten Voorde, Anna M.W., et al.
Publicado: (2021)

MiRNAs Correlate with HLA Expression in Uveal Melanoma: Both Up- and Downregulation Are Related to Monosomy 3
por: Souri, Zahra, et al.
Publicado: (2021)

An Automatic Framework to Create Patient-specific Eye Models From 3D Magnetic Resonance Images for Treatment Selection in Patients With Uveal Melanoma
por: Hassan, Mohamed Kilany, et al.
Publicado: (2021)

MRI of Uveal Melanoma
por: Ferreira, Teresa A., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_rkeqs0090ktefrr3uess9nejrc